[3O06e2] Schizophrenia

[3O06e2-04] Cannabidiol modulates a schizophrenia-like bio-phenotype induced by repeated ketamine

*Charalampos Brakatselos¹, George Ntoulas¹, Michail Zois Asprogerakas¹, Olga Tsarna¹, Alexia Polissidis², Joana Silva³, Ioannis Sotiropoulos³, Joao Filipe Oliveira³, Katerina Antoniou¹ (1. Department of Pharmacology, Faculty of Medicine, School of Health Sciences, University of Ioannina, 45110 Ioannina, Greece, 2. Center of Clinical, Experimental Surgery and Translational Research, Biomedical Research Foundation of the Academy of Athens, 4 Soranou Efesiou Str, 11527 Athens, Greece, 3. Life and Health Sciences Research Institute (ICVS), University of Minho, Braga, Portugal ICVS/3B’s, PT Government Associate Laboratory, Braga, Portugal)

Keywords:cannabidiol, ketamine, schizophrenia, rats